胆汁酸的肝肠循环及肠道微生态在胆汁淤积性肝病发病和治疗中的作用

被引：35

作者：

贾昊宇

杨长青

机构：

[1] 同济大学附属同济医院消化科

来源：

临床肝胆病杂志 | 2019年 / 02期

关键词：

胆汁淤积; 胆酸类; 肝肠循环; 肠道微生物群;

D O I：

暂无

中图分类号：

R575 [肝及胆疾病];

学科分类号：

100201 [内科学];

摘要：

胆汁淤积性肝病是指由病毒、细菌、寄生虫、药物、毒物、自身免疫、酒精、结石、肿瘤和遗传代谢等一系列原因导致胆汁淤积发生而引起的肝脏疾病,主要表现为胆汁流量的改变和胆汁酸毒性的过度积累。在胆汁淤积性肝病的发病过程中,不仅有内源性胆汁酸的肝肠循环作用的参与,且肠道微生物群也通过调节代谢和免疫反应发挥重要作用。除此之外,肠道微生物群与胆汁酸的肝肠循环之间也存在密切的相互作用。胆汁酸可以改变肠道微生物群的组成,反之,肠道微生物也能够影响胆汁酸池。近年来针对胆汁酸的肝肠循环、肠道微生物群与胆汁淤积性肝病之间关系的研究日渐深入,为胆汁淤积性肝病的发病机制及治疗方法提供了一些新的研究方向。

引用

页码：270 / 274

页数：5

共 16 条

[1]

胆汁淤积性肝病诊断和治疗共识(2015)[J] 陈成伟;成军;窦晓光;段钟平;范建高;傅青春;高春芳;韩涛;韩英;侯金林;胡和平;胡锡琪;黄建荣;贾继东;刘玉兰;陆伦根;马雄;茅益民;南月敏;牛俊奇;邱德凯;任红;尚佳;唐红;王贵强;王建设;王吉耀;王磊;王宇明;魏来;谢青;谢渭芬;许建明;徐铭益;徐小元;杨长青;杨云生;尤红;曾民德;张文宏;张跃新;庄辉;周新民;邹晓平; 临床肝胆病杂志 2015, 12

[2]

Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy[J] Ruqi Tang;Yiran Wei;Yanmei Li;Weihua Chen;Haoyan Chen;Qixia Wang;Fan Yang;Qi Miao;Xiao Xiao;Haiyan Zhang;Min Lian;Xiang Jiang;Jun Zhang;Qin Cao;Zhuping Fan;Maoying Wu;Dekai Qiu;Jing-Yuan Fang;Aftab Ansari;M Eric Gershwin;Xiong Ma Gut 2018,

[3]

Novel Therapies on Primary Biliary Cirrhosis[J] Frank Czul;Cynthia Levy Clinics in Liver Disease 2016,

[4]

Implications of microbiota and bile acid in liver injury and regeneration[J] Hui-Xin Liu;Ryan Keane;Lili Sheng;Yu-Jui Yvonne Wan Journal of Hepatology 2015,

[5]

Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4[J] Carolien Out;Jay V. Patankar;Marcela Doktorova;Marije Boesjes;Trijnie Bos;Sanna de Boer;Rick Havinga;Henk Wolters;Renze Boverhof;Theo H. van Dijk;Anna Smoczek;André Bleich;Vinay Sachdev;Dagmar Kratky;Folkert Kuipers;Henkjan J. Verkade;Albert K. Groen Journal of Hepatology 2015,

[6]

Primary biliary cirrhosis[J] Elizabeth J Carey;Ahmad H Ali;Keith D Lindor The Lancet 2015,

[7]

IL-17A Synergistically Enhances Bile Acid–Induced Inflammation during Obstructive Cholestasis[J] Kate M. O'Brien;Katryn M. Allen;Cheryl E. Rockwell;Keara Towery;James P. Luyendyk;Bryan L. Copple The American Journal of Pathology 2013,

[8]

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis[J] James H. Tabibian;Jayant A. Talwalkar;Keith D. Lindor;Jaime Aranda-Michel BioMed Research International 2013,

[9]

Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid; a Naturally Occurring FXR Antagonist[J] Sama I. Sayin;Annika Wahlstr?m;Jenny Felin;Sirkku J?ntti;Hanns-Ulrich Marschall;Krister Bamberg;Bo Angelin;Tuulia Hy?tyl?inen;Matej Ore?i?;Fredrik B?ckhed Cell Metabolism 2013,

[10]

Primary sclerosing cholangitis[J] Gideon M Hirschfield;Tom H Karlsen;Keith D Lindor;David H Adams The Lancet 2013,

← 1 2 →